Abstract: A method for preparing a fiber-containing molding compound includes the acts of a) providing a composite material which includes a first resin and fibers impregnated with the first resin, and b) mixing the composite material with a treatment medium which includes a diluent to form a mixture. The fiber-containing molding compound thus prepared has an adjustable fiber content.

Abstract: Disclosed is a method for manufacturing a reinforced synthetic product with a curved geometry, which includes forming a fabric made of at least one filament bundle including a reinforcing fiber material and at least one thermoplastic filament woven with the filament bundle; and combining a heat-formable material with the fabric to form a bendable fabric preform sheet. Also disclosed is a method for manufacturing a reinforced synthetic product with a curved geometry, which includes positioning the bendable fabric preform sheet into a mold with a curved geometry to form a bended fabric preform sheet; and molding the bended fabric preform sheet by heating to form a cured product.

Abstract: A method for preparing a fiber-containing molding compound includes the acts of a) providing a composite material which includes a first resin and fibers impregnated with the first resin, and b) mixing the composite material with a treatment medium which includes a diluent to form a mixture. The fiber-containing molding compound thus prepared has an adjustable fiber content.

Abstract: The present invention provides a pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease, comprising 50 to 90% by weight of Cordyceps sinensis mycelium powder, and 10 to 50% by weight of condensed astragalus powder.

Abstract: The present invention provides a pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease, comprising 50 to 90% by weight of Cordyceps sinensis mycelium powder, and 10 to 50% by weight of condensed astragalus powder.

Abstract: The present invention provides a pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease, comprising 50 to 90% by weight of Cordyceps sinensis mycelium powder, and 10 to 50% by weight of condensed astragalus powder.

Abstract: The present invention provides a pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease, comprising 50 to 90% by weight of Cordyceps sinensis mycelium powder, and 10 to 50% by weight of condensed astragalus powder.

Abstract: The primary object of the present invention is related to a cylinder lockset with a focusing apparatus which is comprised of a rotary disc, an upper pins seat, a bottom pins seat and a lock pad. The rotary disc of the invention is transfixed with a certain number focusing holes. The upper pins seat is transfixed with a certain number real and dummy corresponding holes & pins. The real corresponding holes of the upper pins seat are corresponded to the focusing holes of rotary disc and be provided with the corresponding pins. The dummy corresponding holes of the upper pins seat have dummy pins, springs and spring pads, which can be or can not be corresponded to the focusing holes of rotary disc. The bottom pins seat is transfixed with a certain number corresponding holes which be provided with corresponding pins, springs that can be corresponded to the real corresponding holes of the upper pins seat and the focusing holes of rotary disc.

Abstract: The present invention relates to the use of hyaluronan in protecting chondrocytes against oxidative damages and further promoting their proliferation. Particularly, the present invention relates to the use of hyaluronan with a molecular weight of 600,000-1,200,000 Dalton in protecting chondrocytes against reactive oxygen damages and further promoting their proliferation.